Inhibitory Potential of Murraya Koenigii (L.) and Ficus Carica L. Extracts Against Aldose Reductase (ALR), Advanced Glycation End Products (AGEs) Formation and Sorbitol Accumulation
By:
References
- 1. Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med. J. 2012 Jul; 27(4):269-73.
- 2. Mehta SR, Kashyap AS, Das S. Diabetes mellitus in India: The modern scourge. Med J. Armed Forces India. 2009 Jan 1; 65(1):50-4.
- 3. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 2014; 37(1).
- 4. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int. 2000 Sep 1; 58:S3-12.
- 5. Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, et al. Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome. Clin J Am Soc Nephrol. 2005 Sep 1; 16(9):2690-701.
- 6. Meier M, Menne J, Park JK, Haller H. Nailing down PKC isoform specificity in diabetic nephropathy—two’s company, three’s a crowd. Nephrol Dial Transplant. 2007; 22:2421-2425.
- 7. Toth C, Rong LL, Yang C, Martinez J, Song F, Ramji N, et al. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy. Diabetes. 2008; 57:1002–17.
- 8. Vareniuk I, Pavlov IA, Obrosova IG. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocininduced mouse model of diabetes. Diabetologia. 2008; 51:2126-33.
- 9. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813–20.
- 10. Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ. Res. 1999 Mar 19; 84(5):489-97.
- 11. Yabe-Nishimura C. Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol Rev. 1998 Mar 1; 50(1):21-34.
- 12. Reddy GB, Muthenna P, Akileshwari C, Saraswat M, Petrash JM. Inhibition of aldose reductase and sorbitol accumulation by dietary rutin. Curr. Sci. 2011 Nov; 10:1191-7.
- 13. Singh R, Kishore L, Kaur N. Diabetic peripheral neuropathy: current perspective and future directions. Pharmacol. Res. Commun. 2014 Feb 1; 80:21-35.
- 14. Jung HA, Jung YJ, Yoon NY, Jeong DM, Bae HJ, Kim DW, et al. Inhibitory effects of Nelumbo nucifera leaves on rat lens aldose reductase, advanced glycation endproducts formation, and oxidative stress. Food Chem. Toxicol. 2008 Dec 1; 46(12):3818-26.
- 15. Vijayanand S. Evaluation of Antidiabetic activity of Murraya koenigii on Alloxan Induced Diabetic rats. Int. J. Pharm. Sci. Res. 2015; 6(12):1401-05.
- 16. Saini SC, Reddy GBS. Murraya koenigii. J Pharm Biol Sci. 2013; 7(6):15-18.
- 17. Vandana J. Murraya Koenigii: An Updated Review. Int. j. Ayurvedic herb. med. 2012; 2(4): 607-627.
- 18. Saini CS, Reddy GBS. A Review on Curry Leaves (Murraya koenigii): Versatile Multi-Potential Medicinal Plant. American Journal of Phytomedicine and Clinical Therapeutics, 2015; 3(4); 363-368.
- 19. Stephen IS, Christudas S, Antony S, Duraipandiyan V, Naif AAD, Ignacimuthu S. Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and β-cells in type 2 diabetic rats. Pharm. Biol. 2017 Jan 1; 55(1):1074-
- 20. Tchombe LN, Louajri A. Therapeutic effects of Ficus carica leaves: A brief review. ARPN J. Sci. Technol. 2015; 5:37-41.
- 21. Badgujar SB, Patel VV, Bandivdekar AH, Mahajan RT. Traditional uses, phytochemistry and pharmacology of Ficus carica: A review. Pharm. Biol. 2014 Nov 1; 52(11):1487-503.
- 22. Krishna MG, Pallavi E, Ravi KB, Ramesh M, Venkatesh S. Hepatoprotective activity of Ficus carica Linn. leaf extract against carbon tetrachloride-induced hepatotoxicity in rats. DARU. 2007; 15(3):162-166.
- 23. Mawa S, Husain K, Jantan I. Ficus carica L. (Moraceae): Phytochemistry, Traditional Uses and Biological Activities. Evid Based Complement Alternat Med. 2013; 2013:974256.
- 24. Kawanishi K, Ueda H, Moriyasu M. Aldose reductase inhibitors from the nature. Curr. Med. 2003 Aug 1; 10(15):1353-74.
- 25. Manzanaro S, Salvá J, de la Fuente JÁ. Phenolic marine natural products as aldose reductase inhibitors. J. Nat. Prod. 2006 Oct 27; 69(10):1485-7.
- 26. de la Fuente JÁ, Manzanaro S, Martín MJ, de Quesada TG, Reymundo I, Luengo SM, et al. Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product. J. Med. Chem. 2003 Nov 20; 46(24):5208-21.
- 27. Saraswat M, Muthenna P, Suryanarayana P, Petrash JM, Reddy GB. Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications. Asia Pac. J. Clin. Nutr. 2008 Dec 1; 17(4) ):558-65.
- 28. Matsuda H, Wang T, Managi H, Yoshikawa M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg. Med. Chem. 2003 Dec 1; 11(24):5317-23.
- 29. Haraguchi H, Ohmi I, Fukuda A, Tamura Y, Mizutani K, Tanaka O, et al. Inhibition of aldose reductase and sorbitol accumulation by astilbin and taxifolin dihydroflavonols in Engelhardtia chrysolepis. Biosci Biotechnol Biochem. 1997 Apr 23; 61(4):651-4.
- 30. Singh R, Kaur N, Kishore L, Gupta GK. Management of diabetic complications: a chemical constituents based approach. J. Ethnopharmacol. 2013 Oct 28; 150(1): 51-70.
- 31. Kajal A, Singh R. Modulation of advanced glycation end products, sorbitol, and aldose reductase by hydroalcohol extract of Lagenaria siceraria mol standl in diabetic complications: an in vitro approach. J. Diet. Suppl. 2018 Jul 4; 15(4):482-98.
- 32. Kishore L, Kaur N, Kajal A, Singh R. Extraction, characterization and evaluation of Eruca sativa against streptozotocin- induced diabetic nephropathy in rat. Bangladesh J. Pharmacol. 2017 Jun 30; 12(2):216-27.
- 33. da Silva Morrone M, de Assis AM, da Rocha RF, Gasparotto J, Gazola AC, Costa GM, et al. Passiflora manicata (Juss.) aqueous leaf extract protects against reactive oxygen species and protein glycation in vitro and ex vivo models. Food Chem. Toxicol. 2013 Oct 1; 60:45-51.
- 34. Kishore L, Kaur N, Singh R. Renoprotective effect of Bacopa monnieri via inhibition of advanced glycation end products and oxidative stress in STZ-nicotinamideinduced diabetic nephropathy. Ren. Fail. 2016 Oct 20;3 8(9):1528-44.
- 35. Shimizu M, Ito T, Terashima S, Hayashi T, et. al. Inhibition of lens aldose reductase by flavonoids. Phytochemistry. 1984; 23(9):1885-8.
- 36. Ghamali M, Chtita S, Hmamouchi R, Adad A, Bouachrine M, Lakhlifi T. The inhibitory activity of aldose reductase of flavonoid compounds: Combining DFT and QSAR calculations. J. Tiabah Univ. Sci. 2016; 10(4):534-42.
- 37. Patil KK, Gacche RN. Inhibition of glycation and aldose reductase activity using dietary flavonoids: A lens organ culture studies. Int. J. Biol. Macromol. 2017; 98:730-8.
- 38. Aju BY, Rajalakshmi R, Mini S. Evaluation of antioxidant activity of Murraya koenigii (L.) Spreng using different in vitro methods. J. Pharmacogn. Phytochem. 2017; 6(4): 939-942.
- 39. Trifunschi SI, Ardelean DG. Flavonoid extraction from Ficus carica leaves using different techniques and solvents. Zbornik Matice srpske za prirodne nauke. 2013(125):81-6.
Language: English
Page range: 125 - 130
Submitted on: Jul 10, 2020
Accepted on: Sep 19, 2020
Published on: Aug 5, 2021
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2021 Shah Asma Farooq, Randhir Singh, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.